Source:http://linkedlifedata.com/resource/umls/id/C1881112
NCI: An induction regimen consisting of dexamethasone, cytarabine, thioguanine, etoposide and idarubicin administered on an intensively-timed schedule as a form of timed-sequential therapy and used for the treatment of childhood acute myeloid leukemia.